Navigation Links
Hanger Orthopedic Group, Inc. Reports an Increase of 42.3% in Earnings Per Share, to $0.37 on a 10.6% Sales Increase, for the Fourth Quarter 2009
Date:2/10/2010

described below occurred and the preferred stock was converted to common stock at the beginning of the period.  Net income applicable to common stock for year ended December 31, 2008 on a GAAP basis was $21.1 million, or $0.78 per diluted share.

Cash from operations for the year ended December 31, 2008 was $73.1 million, a $19.9 million, or 37.4% increase, compared to 2008. The improvement was primarily the result of improved operating results. The Company had total liquidity of $148.5 million, comprised of $84.6 million of cash and $63.9 million available under its revolving credit facility at December 31, 2009.  

"The year 2009 presented a challenging environment due to the uncertainty surrounding proposed changes to federal health care regulations and reimbursement and the impact of the ongoing recession.  In spite of these challenges, we delivered record sales, profits and cash flows," commented Thomas F. Kirk, President and Chief Executive Officer of Hanger Orthopedic Group.  Mr. Kirk added, "The combination of an 8.1% increase in revenue and a focused effort on expense management generated an 80 basis point improvement in our operating margin.   I am proud of our employees' efforts in 2009 and I am optimistic about our opportunities in 2010."

For 2010, the Company expects revenues to be between $815 million and $825 million an increase of 7.2 % to 8.5% compared to 2009.  The Company expects diluted EPS for 2010 to be in the range of $1.27 to $1.29, which would represent a 12.4% to 14.2% increase over 2009 d
'/>"/>

SOURCE Hanger Orthopedic Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call
2. Hanger Orthopedic Group Increases Q4 2009 Sales and EPS Guidance
3. Hanger Orthopedic Group, Inc. Announces Three Acquisitions Totaling $10.7 Million of Annual Net Revenue
4. Medstrat Partners with Major Orthopedic Company
5. Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics
6. Reportlinker Adds Top Ten Worlds Leading Orthopedics Companies
7. Ascension Orthopedics Hires Key Senior Executives
8. Reportlinker Adds Orthopedic Prosthetics - A World Market Review
9. Reportlinker Adds U.S. Market for Small Bone & Joint Orthopedic Devices 2009
10. Reportlinker Adds European Markets for Orthopedic Biomaterials 2009 (15 Countries)
11. Pioneer(R) Surgical Technology, Inc. and Bonovo(R) Orthopedics, Inc. Establish Foothold in Fastest Growing Spine Market in the World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Pa. , May 21, 2013  Lehigh Valley ... TRU-D SmartUVC TM devices, adding to its existing ... seven devices taking up residence within the network, LVHN ... the U.S. to proactively combat superbugs and provide the ... for Total Room Ultraviolet Disinfector, TRU-D – the signature ...
(Date:5/21/2013)... , May 21, 2013  Janssen R&D Ireland ... from the global Phase 3 PROMISE study demonstrating ... (TMC435) led to sustained virologic response 12 weeks ... percent of treatment-experienced genotype 1 chronic hepatitis C ... stages of liver fibrosis, when administered once daily ...
(Date:5/21/2013)... -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: ... cell based therapies for various personal applications, announced that ... CEO, will be presenting at the Marcum MicroCap Conference.   ... Thursday, May 30, 2013 at the Grand Hyatt Hotel, ... City.  Mr. Weinreb,s presentation will take place at 2:30 ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
... , , SOUTHFIELD, Mich. ... ., (Nasdaq: TEAM ), a worldwide provider of information ... it has named Guido Roumans as director of global life ... management and ongoing capability enhancement in support of TechTeam,s life ...
... , MUMBAI, India , Feb. 9 ... a presence in India , Western and Central Eastern ... alliance with DreamCIS Inc., a leading CRO based in ... decade of experience in offering clinical research services to pharmaceutical ...
Cached Medicine Technology:TechTeam Global Appoints Life Sciences Services Director 2TechTeam Global Appoints Life Sciences Services Director 3SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS 2SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS 3
(Date:5/21/2013)... Global Proving Ground (GPG), a fast ... online retailer of health and fitness supplements, are partnering ... Warrior Island. “We cast the show by having ... with our unique social networking platform,” states show’s creator ... on an island in the Pacific Ocean, where they ...
(Date:5/21/2013)... Boston, Mass.By studying the roles two proteins, thrombospondin-1 ... trans-Atlantic research team has identified a five-amino acid ... in mouse models of prostate, breast and lung ... could potentially block metastasis in a variety of ... Randolph Watnick, PhD, at Boston Children,s Hospital, Vivek ...
(Date:5/21/2013)... adenoids and tonsils, is performed 500,000 times a year ... children with obstructive sleep apnea. However, the procedure,s ... behavior, sleep apnea symptoms, and quality of life has ... led by Susan Redline, MD, MPH, director of ... Clinic Director of the Division of Sleep Medicine at ...
(Date:5/21/2013)... 2013 Go Classy Tours, the oldest ... have redesigned their website featuring N Resort in ... tubs, bars and dining. The website, which has always ... and guest reviews, will now have a broader range ... pages on culinary local recipes, flora and fauna, featured ...
(Date:5/21/2013)... The American Diabetes Association ( http://goo.gl/YRSF1 ... United States of America are affected with peripheral neuropathy. ... risk of developing peripheral neuropathy which unfortunately makes it ... further goes on saying that the disease usually affects ... million new cases are diagnosed every year in the ...
Breaking Medicine News(10 mins):Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2
... A simpler form of testing individuals with risk ... substantially increasing the number of individuals who complete testing ... develop diabetes. Approximately 60 million Americans, one-third of ... individuals will develop Type 2 diabetes in less than ...
... technical, medical, and scholarly publishing business of John ... today that an additional 88 journals and 24 ... United Nations sponsored Research4Life programs that provide developing ... and training for academic and professional peer-reviewed content ...
... HealthDay Reporter , WEDNESDAY, Jan. 5 (HealthDay News) ... be reviewed by the U.S. Food and Drug Administration if ... Wednesday. This effort, one aspect of the 2009 Family ... more addictive products from the hands of consumers. Any new ...
... HealthDay Reporter , WEDNESDAY, Jan. 5 (HealthDay News) -- ... vigorous physical exercise appear to lower their risk of dying ... week or more of vigorous biking, tennis, jogging or swimming ... team found. But they added that even moderate physical activity ...
... , WEDNESDAY, Jan. 5 (HealthDay News) -- DNA can ... criminal who is being sought by police, Dutch researchers report. ... in determining whether a person has red hair or black ... hair. The necessary DNA can be taken from blood, sperm, ...
... Dr. Emil Kozarov and a team of researchers at ... specific bacteria that may have a key role in ... to as "hardening of the arteries" the number ... Fully understanding the role of infections in cardiovascular diseases ...
Cached Medicine News:Health News:Routine blood test may identify people with pre-diabetes, cutting later treatment costs 2Health News:Routine blood test may identify people with pre-diabetes, cutting later treatment costs 3Health News:Wiley-Blackwell announces 102 additional products available through Research4Life 2Health News:FDA Launches Review of Tobacco Products 2Health News:Exercise May Improve Odds Against Prostate Cancer Death 2Health News:Exercise May Improve Odds Against Prostate Cancer Death 3Health News:Exercise May Improve Odds Against Prostate Cancer Death 4Health News:Bacteria eyed for possible role in atherosclerosis 2Health News:Bacteria eyed for possible role in atherosclerosis 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: